<DOC>
	<DOCNO>NCT02565953</DOCNO>
	<brief_summary>In recent year use paclitaxel release percutaneous transluminal angioplastic ( PTA ) balloon catheter spread vascular pathology , mainly stenosis infrainguinal artery . This device combine mechanical action PTA balloon antiproliferative effect paclitaxel . The use device venous pathology limit . This device could improve treatment renal dialysis arteriovenous fistula stenosis .</brief_summary>
	<brief_title>Primary Patency Post-angioplasty Dysfunctional Arteriovenous Fistula Renal Dialysis : Paclitaxel-releasing PTA Balloon Catheter v PTA Balloon</brief_title>
	<detailed_description />
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Arteriovenous Fistula</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Patient renal dialysis arteriovenous fistula ( AVF ) least 3 month . Patient diagnose AVF stenosis clinical radiological criterion Sign inform consent Pregnant breastfeeding Patients AVF stenosis could treat PTA catheter Paclitaxel allergy Iodinated contrast allergy Local systemic active infection Life expectancy le 12 moth</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Vascular access device obstruction</keyword>
</DOC>